Treating mice with MCC950, a small-molecule NLRP3-specific inhibitor, reduced endometriosis lesion size, suggesting a pathogenic role of NLRP3 hyperactivation in endometriosis (6). This evidence concerns the gene NLRP3 and endometriosis.